Regenxbio: Dosing of first patient in Phase 2 AAVIATE trial for wet AMD

September 09, 2020

Interim data update from first cohort using suprachoroidal delivery of RGX-314 expected by end of 2020

Deep learning algorithm proving accurate for AMD classification

September 01, 2020

Results of a prospective trial show the tool is ready for clinical use and potential deployment for remote telemedical use.

Contrast sensitivity shows potential for measuring visual function loss in early AMD

September 01, 2020

A study suggests this user-friendly platform may be useful as a supplemental visual function measure in patients with AMD.